BOSTON SCIENTIFIC CORPORATION (BSX) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Win; EPS growth Win.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Win.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Win.
73/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 6 wins, 6 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseBSX / S&P -31.98% / 15.20% |
LoseBSX / S&P 13.53% / 15.00% |
LoseBSX / S&P 47.02% / 50.40% |
| 2026-Q12/3 |
LoseBSX / S&P -34.19% / -4.33% |
WinBSX / S&P 17.44% / 11.30% |
WinBSX / S&P 74.45% / 27.70% |
| 2025-Q42/3 |
LoseBSX / S&P -2.34% / 2.65% |
WinBSX / S&P 19.88% / 9.00% |
WinBSX / S&P 55.20% / 13.40% |
| 2025-Q32/3 |
LoseBSX / S&P -9.11% / 8.12% |
WinBSX / S&P 21.62% / 4.61% |
WinBSX / S&P 54.55% / 13.45% |
| 2025-Q22/3 |
LoseBSX / S&P 6.47% / 10.94% |
WinBSX / S&P 21.45% / 4.83% |
WinBSX / S&P 36.59% / 10.63% |
| 2025-Q13/3 |
WinBSX / S&P 12.94% / -4.27% |
WinBSX / S&P 19.35% / 4.98% |
WinBSX / S&P 15.13% / 10.57% |
| 2024-Q43/3 |
WinBSX / S&P 6.59% / 2.41% |
WinBSX / S&P 17.60% / 5.25% |
WinBSX / S&P 16.82% / 6.15% |
| 2024-Q33/3 |
WinBSX / S&P 8.82% / 5.89% |
WinBSX / S&P 15.65% / 5.89% |
WinBSX / S&P 47.56% / 6.11% |
| 2024-Q23/3 |
WinBSX / S&P 12.44% / 4.28% |
WinBSX / S&P 13.64% / 5.38% |
WinBSX / S&P 105.00% / 5.12% |
| 2024-Q13/3 |
WinBSX / S&P 18.47% / 10.56% |
WinBSX / S&P 12.74% / 5.71% |
WinBSX / S&P 101.69% / 5.59% |
| 2023-Q42/3 |
LoseBSX / S&P 9.49% / 11.69% |
WinBSX / S&P 12.29% / 6.81% |
WinBSX / S&P 137.78% / 7.78% |
| 2023-Q33/3 |
WinBSX / S&P -2.38% / -3.27% |
WinBSX / S&P 9.47% / 7.52% |
WinBSX / S&P 95.24% / -5.03% |
| 2023-Q21/3 |
LoseBSX / S&P 8.12% / 8.74% |
LoseBSX / S&P 8.69% / 9.50% |
WinBSX / S&P 3.45% / -8.57% |
| 2023-Q12/3 |
WinBSX / S&P 8.13% / 7.50% |
LoseBSX / S&P 7.26% / 10.77% |
WinBSX / S&P 11.32% / -15.69% |
| 2022-Q41/3 |
WinBSX / S&P 19.47% / 7.56% |
LoseBSX / S&P 6.68% / 11.88% |
LoseBSX / S&P -34.78% / -17.99% |
| 2022-Q31/3 |
WinBSX / S&P 3.92% / -4.88% |
LoseBSX / S&P 9.56% / 13.47% |
LoseBSX / S&P -45.45% / -1.41% |
| 2022-Q22/3 |
WinBSX / S&P -15.85% / -16.10% |
LoseBSX / S&P 10.11% / 13.71% |
WinBSX / S&P 56.76% / 11.04% |
| 2022-Q13/3 |
WinBSX / S&P 4.26% / -4.60% |
WinBSX / S&P 20.14% / 15.97% |
WinBSX / S&P 278.57% / 42.23% |
| 2021-Q41/3 |
LoseBSX / S&P -2.10% / 11.03% |
WinBSX / S&P 19.91% / 15.00% |
LoseBSX / S&P -962.50% / 96.40% |
| 2021-Q32/3 |
WinBSX / S&P 1.47% / 0.58% |
WinBSX / S&P 13.46% / 10.77% |
LoseBSX / S&P -70.50% / 69.42% |
| 2021-Q22/3 |
WinBSX / S&P 10.63% / 8.55% |
WinBSX / S&P 10.24% / 6.58% |
LoseBSX / S&P -86.88% / 51.81% |
| 2021-Q11/3 |
WinBSX / S&P 7.51% / 6.17% |
LoseBSX / S&P -6.14% / -1.06% |
LoseBSX / S&P -95.39% / 7.39% |
| 2020-Q40/3 |
LoseBSX / S&P -5.91% / 12.15% |
LoseBSX / S&P -7.65% / -3.72% |
LoseBSX / S&P -102.40% / -33.42% |
| 2020-Q31/3 |
LoseBSX / S&P 8.83% / 8.93% |
LoseBSX / S&P -2.72% / -2.04% |
WinBSX / S&P 238.96% / -27.10% |
| 2020-Q22/3 |
LoseBSX / S&P 7.60% / 20.54% |
WinBSX / S&P 0.78% / -0.46% |
WinBSX / S&P 184.85% / -27.11% |
| 2020-Q12/3 |
LoseBSX / S&P -27.84% / -19.60% |
WinBSX / S&P 8.53% / 3.47% |
WinBSX / S&P 137.50% / -14.75% |
| 2019-Q43/3 |
WinBSX / S&P 11.13% / 9.07% |
WinBSX / S&P 9.28% / 5.36% |
WinBSX / S&P 179.83% / 2.99% |
| 2019-Q32/3 |
LoseBSX / S&P -5.33% / 1.70% |
WinBSX / S&P 7.47% / 5.02% |
WinBSX / S&P 60.42% / 0.21% |
| 2019-Q22/3 |
WinBSX / S&P 11.99% / 4.30% |
LoseBSX / S&P 6.10% / 6.64% |
WinBSX / S&P 167.57% / 8.65% |
| 2019-Q11/3 |
LoseBSX / S&P 8.60% / 13.65% |
LoseBSX / S&P 7.24% / 8.12% |
WinBSX / S&P 1500.00% / 14.29% |
| 2018-Q42/3 |
WinBSX / S&P -8.21% / -13.52% |
LoseBSX / S&P 8.58% / 9.05% |
WinBSX / S&P 1387.50% / 18.23% |
| 2018-Q31/3 |
WinBSX / S&P 17.74% / 7.71% |
LoseBSX / S&P 9.51% / 10.21% |
LoseBSX / S&P -21.31% / 19.06% |
| 2018-Q21/3 |
WinBSX / S&P 19.69% / 3.43% |
LoseBSX / S&P 9.02% / 9.03% |
LoseBSX / S&P -36.21% / 14.46% |
| 2018-Q12/3 |
WinBSX / S&P 10.21% / -0.76% |
WinBSX / S&P 7.97% / 7.68% |
LoseBSX / S&P -75.00% / 12.46% |
| 2017-Q41/3 |
LoseBSX / S&P -15.02% / 6.64% |
WinBSX / S&P 7.88% / 7.03% |
LoseBSX / S&P -69.23% / 13.82% |
| 2017-Q33/3 |
WinBSX / S&P 5.23% / 4.48% |
WinBSX / S&P 8.04% / 5.68% |
WinBSX / S&P 916.67% / 17.57% |
| 2017-Q22/3 |
WinBSX / S&P 11.46% / 3.09% |
WinBSX / S&P 9.51% / 4.83% |
LoseBSX / S&P -323.08% / 17.74% |
| 2017-Q12/3 |
WinBSX / S&P 14.98% / 6.07% |
WinBSX / S&P 11.85% / 3.67% |
LoseBSX / S&P -1166.67% / 13.32% |
| 2016-Q41/3 |
LoseBSX / S&P -9.12% / 3.82% |
WinBSX / S&P 12.16% / 2.09% |
LoseBSX / S&P -244.44% / 7.05% |
| 2016-Q31/3 |
LoseBSX / S&P 1.84% / 3.85% |
WinBSX / S&P 10.66% / 0.20% |
LoseBSX / S&P -120.69% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | BSX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -55.76% | 20.78% |
| Annualized return | -55.76% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | BSX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 2.39% | 83.14% |
| Annualized return | 0.47% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | BSX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 91.82% | 319.30% |
| Annualized return | 6.73% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |